Gracner T, Naji M, Hudovernik M, Gracner B, Pahor D
Universitätskrankenhaus Maribor, Augenabteilung, Slowenien (Vorstand: Prof. Dr. Dr. med. Dusica Pahor).
Klin Monbl Augenheilkd. 2007 Dec;224(12):922-6. doi: 10.1055/s-2007-963744.
The aim of this study was to determine factors that predict successful selective laser trabeculoplasty (SLT) in open-angle glaucoma (OAG).
In 122 eyes suffering from OAG, treatment was carried out with a frequency-doubled, Q-switched Nd:YAG laser (532 nm). The intraocular pressure (IOP) was measured before the treatment and 1, 3, 6, 12, 18, 24, 30, 36, 42, 48, 54, 60, 66, 72, 78 and 84 months thereafter. Success was defined as an IOP reduction exceeding 20 % of the pretreatment IOP. Correlations between successful SLT and baseline IOP, age, sex, hypertension, diabetes mellitus, family history of glaucoma, previous anterior segment surgery, the grade of trabecular meshwork pigmentation, laser energy used, and local antiglaucoma therapy were determined.
The mean follow-up time was 43.4 months (SD: 25.6). The mean pretreatment IOP was 22.5 mmHg (SD: 2.8). The success rate after 12 months determined from the Kaplan-Meier survival analysis was 88 %, after 24 months 79 %, after 36 months 67 %, after 48 months 58 %, after 60 months 49 % and after 84 months 48 %. We found statistically significant negative correlation betweens successful SLT and the grade of trabecular meshwork pigmentation (r = -0.234; p = 0.01), diabetes mellitus (r = -0.223; p = 0.014). We found no statistically significant correlations between successful SLT and baseline IOP, age, sex, hypertension, family history of glaucoma, previous anterior segment surgery, laser energy used, local antiglaucoma therapy.
SLT success in OAG with a mean follow-up time of 43.4 months was significantly predicted by the lower grade of trabecular meshwork pigmentation and the absence of diabetes mellitus.
本研究旨在确定预测开角型青光眼(OAG)患者选择性激光小梁成形术(SLT)成功的因素。
对122例OAG患者的眼睛,使用倍频Q开关Nd:YAG激光(532nm)进行治疗。在治疗前以及治疗后1、3、6、12、18、24、30、36、42、48、54、60、66、72、78和84个月测量眼压(IOP)。成功定义为眼压降低超过治疗前眼压的20%。确定了SLT成功与基线眼压、年龄、性别、高血压、糖尿病、青光眼家族史、既往眼前节手术、小梁网色素沉着程度、使用的激光能量以及局部抗青光眼治疗之间的相关性。
平均随访时间为43.4个月(标准差:25.6)。治疗前平均眼压为22.5mmHg(标准差:2.8)。根据Kaplan-Meier生存分析,12个月后的成功率为88%,24个月后为79%,36个月后为67%,48个月后为58%,60个月后为49%,84个月后为48%。我们发现SLT成功与小梁网色素沉着程度(r = -0.234;p = 0.01)、糖尿病(r = -0.223;p = 0.014)之间存在统计学显著负相关。我们未发现SLT成功与基线眼压、年龄、性别、高血压、青光眼家族史、既往眼前节手术、使用的激光能量、局部抗青光眼治疗之间存在统计学显著相关性。
小梁网色素沉着程度较低且无糖尿病可显著预测平均随访时间为43.4个月的OAG患者SLT治疗成功。